PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

meclizine Side Effects

The reactions most often reported to the FDA for meclizine (also sold as Antivert, Bonine), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

15,616
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 2004 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of meclizine come from 15,616 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 15,616 reports to the FDA Adverse Event Reporting System (FAERS) for meclizine (Antivert): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

15,616

Reports Mentioning Death

1,426

9.1% of reports — not proof the medicine caused the death

Hospitalizations

4,910

31.4% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

DIZZINESS
1,570
NAUSEA
1,351
FATIGUE
1,303
HEADACHE
1,010
DIARRHOEA
991
PAIN
985
FALL
965
DYSPNOEA
851
CHRONIC KIDNEY DISEASE
839
ASTHENIA
793
VOMITING
691
RENAL FAILURE
639
ANXIETY
607
VERTIGO
606
ACUTE KIDNEY INJURY
579
ARTHRALGIA
543
DEATH
531
PAIN IN EXTREMITY
515

Who Reports Side Effects

Gender Distribution

Female 10,928 (74%)
Male 3,808 (26%)
Unknown 10

Age Distribution

0-17 132 (1%)
18-44 1,197 (12%)
45-64 3,350 (35%)
65-74 2,389 (25%)
75+ 2,512 (26%)

Reporting Trend by Year

2004 2025

Reactions in Death Reports

Top reactions reported in 1,426 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
DEATH 530
COMPLETED SUICIDE 180
TOXICITY TO VARIOUS AGENTS 133
RENAL FAILURE 109
CHRONIC KIDNEY DISEASE 101
ACUTE KIDNEY INJURY 93
NAUSEA 78
PNEUMONIA 77
FALL 76
ASTHENIA 70
CARDIAC FAILURE CONGESTIVE 70
DYSPNOEA 68
PAIN 68
END STAGE RENAL DISEASE 66
FATIGUE 66
DIZZINESS 62
CARDIAC ARREST 60
DIARRHOEA 59
HYPOTENSION 57
ANXIETY 51

Reactions in Hospitalization Reports

Top reactions in 4,910 reports where hospitalization was an outcome.

Reaction Reports
DIZZINESS 560
FALL 560
NAUSEA 500
DYSPNOEA 410
PAIN 400
ASTHENIA 393
FATIGUE 388
DIARRHOEA 358
PNEUMONIA 356
VOMITING 333
HEADACHE 301
URINARY TRACT INFECTION 291
ANXIETY 267
CHEST PAIN 266
CEREBROVASCULAR ACCIDENT 260
VERTIGO 249
ACUTE KIDNEY INJURY 242
RENAL FAILURE 233
HYPERTENSION 230
DEHYDRATION 228

Compare meclizine vs azelastine →

What the FAERS Data Reveals About meclizine Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 15,616 voluntary reports linked to meclizine and its brand equivalents (Antivert, Bonine), spanning 2004 through 2025. Of those, 1,426 (9.1%) listed death as an outcome and 4,910 (31.4%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 74% were female and 26% male; age distribution skews toward 45-64, with 3,350 reports in that bracket. The single most reported reaction is dizziness with 1,570 submissions, followed by nausea and fatigue.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.